Biblio

Export 289 results:
Author Title Type [ Year(Desc)]
Filters: First Letter Of Title is P  [Clear All Filters]
2011
M. Jucker and Walker, L. C., “Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders.”, Ann Neurol, vol. 70, no. 4, pp. 532-40, 2011.
2012
J. J. Iliff, Wang, M., Liao, Y., Plogg, B. A., Peng, W., Gundersen, G. A., Benveniste, H., G Vates, E., Deane, R., Goldman, S. A., Nagelhus, E. A., and Nedergaard, M., “A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid β.”, Sci Transl Med, vol. 4, no. 147, p. 147ra111, 2012.
J. Zhou, Gennatas, E. D., Kramer, J. H., Miller, B. L., and Seeley, W. W., “Predicting regional neurodegeneration from the healthy brain functional connectome.”, Neuron, vol. 73, no. 6, pp. 1216-27, 2012.
A. de Calignon, Polydoro, M., Suárez-Calvet, M., William, C., Adamowicz, D. H., Kopeikina, K. J., Pitstick, R., Sahara, N., Ashe, K. H., Carlson, G. A., Spires-Jones, T. L., and Hyman, B. T., “Propagation of tau pathology in a model of early Alzheimer's disease.”, Neuron, vol. 73, no. 4, pp. 685-97, 2012.
2014
R. S. Doody, Thomas, R. G., Farlow, M., Iwatsubo, T., Vellas, B., Joffe, S., Kieburtz, K., Raman, R., Sun, X., Aisen, P. S., Siemers, E., Liu-Seifert, H., and Mohs, R., “Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 311-21, 2014.
M. Mapstone, Cheema, A. K., Fiandaca, M. S., Zhong, X., Mhyre, T. R., MacArthur, L. H., Hall, W. J., Fisher, S. G., Peterson, D. R., Haley, J. M., Nazar, M. D., Rich, S. A., Berlau, D. J., Peltz, C. B., Tan, M. T., Kawas, C. H., and Federoff, H. J., “Plasma phospholipids identify antecedent memory impairment in older adults.”, Nat Med, vol. 20, no. 4, pp. 415-8, 2014.
2015
R. Remington, Bechtel, C., Larsen, D., Samar, A., Doshanjh, L., Fishman, P., Luo, Y., Smyers, K., Page, R., Morrell, C., and Shea, T. B., “A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
2016
A. Malara, De Biase, G. Andrea, Bettarini, F., Ceravolo, F., Di Cello, S., Garo, M., Praino, F., Settembrini, V., Sgrò, G., Spadea, F., and Rispoli, V., “Pain Assessment in Elderly with Behavioral and Psychological Symptoms of Dementia.”, J Alzheimers Dis, vol. 50, no. 4, pp. 1217-25, 2016.
D. W. Scharre, Chang, S. - I., Nagaraja, H. N., Park, A., Adeli, A., Agrawal, P., Kloos, A., Kegelmeyer, D., Linder, S., Fritz, N., Kostyk, S. K., and Kataki, M., “Paired Studies Comparing Clinical Profiles of Lewy Body Dementia with Alzheimer's and Parkinson's Diseases.”, J Alzheimers Dis, vol. 54, no. 3, pp. 995-1004, 2016.
A. Gabelle, Gutierrez, L. - A., Dartigues, J. - F., Ritchie, K., Touchon, J., and Berr, C., “Palmomental Reflex a Relevant Sign in Early Alzheimer's Disease Diagnosis?”, J Alzheimers Dis, vol. 49, no. 4, pp. 1135-41, 2016.
G. Allali, Garibotto, V., and Assal, F., “Parkinsonism Differentiates Idiopathic Normal Pressure Hydrocephalus from Its Mimics.”, J Alzheimers Dis, vol. 54, no. 1, pp. 123-7, 2016.
Y. Deng, Wei, J., Cheng, J., Zhong, P., Xiong, Z., Liu, A., Lin, L., Chen, S., and Yan, Z., “Partial Amelioration of Synaptic and Cognitive Deficits by Inhibiting Cofilin Dephosphorylation in an Animal Model of Alzheimer's Disease.”, J Alzheimers Dis, vol. 53, no. 4, pp. 1419-32, 2016.
N. Voyle, Keohane, A., Newhouse, S., Lunnon, K., Johnston, C., Soininen, H., Kloszewska, I., Mecocci, P., Tsolaki, M., Vellas, B., Lovestone, S., Hodges, A., Kiddle, S., and Dobson, R. Jb, “A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.”, J Alzheimers Dis, vol. 49, no. 3, pp. 659-69, 2016.
K. Sakai, Senda, T., Hata, R., Kuroda, M., Hasegawa, M., Kato, M., Abe, M., Kawaguchi, K., Nakai, S., Hiki, Y., Yuzawa, Y., and Kitaguchi, N., “Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid.”, J Alzheimers Dis, vol. 51, no. 4, pp. 997-1002, 2016.
B. Hanseeuw, Dricot, L., Lhommel, R., Quenon, L., and Ivanoiu, A., “Patients with Amyloid-Negative Mild Cognitive Impairment have Cortical Hypometabolism but the Hippocampus is Preserved.”, J Alzheimers Dis, vol. 53, no. 2, pp. 651-60, 2016.
G. Fernández, Manes, F., Politi, L. E., Orozco, D., Schumacher, M., Castro, L., Agamennoni, O., and Rotstein, N. P., “Patients with Mild Alzheimer's Disease Fail When Using Their Working Memory: Evidence from the Eye Tracking Technique.”, J Alzheimers Dis, vol. 50, no. 3, pp. 827-38, 2016.
Y. Moon, Han, S. - H., and Moon, W. - J., “Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging.”, J Alzheimers Dis, vol. 51, no. 3, pp. 737-45, 2016.
A. Pistono, Jucla, M., Barbeau, E. J., Saint-Aubert, L., Lemesle, B., Calvet, B., Köpke, B., Puel, M., and Pariente, J., “Pauses During Autobiographical Discourse Reflect Episodic Memory Processes in Early Alzheimer's Disease.”, J Alzheimers Dis, vol. 50, no. 3, pp. 687-98, 2016.
A. F. Teich, Sakurai, M., Patel, M., Holman, C., Saeed, F., Fiorito, J., and Arancio, O., “PDE5 Exists in Human Neurons and is a Viable Therapeutic Target for Neurologic Disease.”, J Alzheimers Dis, vol. 52, no. 1, pp. 295-302, 2016.
D. Chiasserini, Biscetti, L., Farotti, L., Eusebi, P., Salvadori, N., Lisetti, V., Baschieri, F., Chipi, E., Frattini, G., Stoops, E., Vanderstichele, H., Calabresi, P., and Parnetti, L., “Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical Routine.”, J Alzheimers Dis, vol. 54, no. 1, pp. 55-67, 2016.
P. Suppa, Hampel, H., Kepp, T., Lange, C., Spies, L., Fiebach, J. B., Dubois, B., and Buchert, R., “Performance of Hippocampus Volumetry with FSL-FIRST for Prediction of Alzheimer's Disease Dementia in at Risk Subjects with Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 51, no. 3, pp. 867-73, 2016.
J. Benito-León, Contador, I., Mitchell, A. J., Domingo-Santos, Á., and Bermejo-Pareja, F., “Performance on Specific Cognitive Domains and Cause of Death: A Prospective Population-Based Study in Non-Demented Older Adults (NEDICES).”, J Alzheimers Dis, vol. 51, no. 2, pp. 533-44, 2016.
D. G. Amen, Willeumier, K., Omalu, B., Newberg, A., Raghavendra, C., and Raji, C. A., “Perfusion Neuroimaging Abnormalities Alone Distinguish National Football League Players from a Healthy Population.”, J Alzheimers Dis, vol. 53, no. 1, pp. 237-41, 2016.
S. A. Farr, Sandoval, K. E., Niehoff, M. L., Witt, K. A., Kumar, V. B., and Morley, J. E., “Peripheral Administration of GSK-3β Antisense Oligonucleotide Improves Learning and Memory in SAMP8 and Tg2576 Mouse Models of Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1339-1348, 2016.
C. L. Parham, Shaw, C., Auckland, L. D., S Dickeson, K., Griswold-Prenner, I., and Bix, G., “Perlecan Domain V Inhibits Amyloid-β Induced Activation of the α2β1 Integrin-Mediated Neurotoxic Signaling Cascade.”, J Alzheimers Dis, vol. 54, no. 4, pp. 1629-1647, 2016.

Pages